As 2023 midpoint nears, signs of life emerge in biopharma dealmaking
The year’s first six months reveal a clear appetite for biopharma M&A, although an emboldened FTC has made dealmakers wary.
Source: mmm-online.com
Page 8 - Evaluate Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Evaluate Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Evaluate Pharma Today - Breaking & Trending Today
Global Pharmaceutical Contract Sales Organizations Market
Dublin, June 05, 2023 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Sales Organizations Market Size, Share & Trends Analysis Report By Services...
Source: globenewswire.com
Seven Biopharma Trends to Watch in 2023
Key trends include fewer and slower financings, a surge of decisive data readouts for cancer vaccines, and further development of mRNA, cell, and gene therapies.
Source: genengnews.com
Seven Biopharma Trends to Watch in 2023
Key trends include fewer and slower financings, a surge of decisive data readouts for cancer vaccines, and further development of mRNA, cell, and gene therapies.
Source: genengnews.com
Biotech's Market Outlook In 2023 Beyond
This article discusses three key themes in 2023 that are likely to have an outsized impact on biotech companies as well as the notable longer-term...
Source: lifescienceleader.com